NowoTrade

NVS

NVS Novartis AG

Stock · NYSE · Switzerland · Healthcare · US66987V1098

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Novartis AG, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 162.55 USD +0.38%
52-week range 123.24 – 170.46
Dividend yield2.92%
Market cap307.0B
NowoTrade score 58 Grade A

Price history

Daily prices in USD.

Updated 08 Nov 2026 14:45. Information, not advice.

Results

Next results 03 Feb 2027 in 87 days · 08:00 · estimate 2.23
Last results 2.46 vs 2.24 estimated 27 Oct 2026 · Beat +9.7%
Beat the estimate 9 of 12 2 missed · 1 in line · 2 beats in a row
Average surprise +4.3% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

30 Jan 2024: estimate 1.66 30 Jan 2024: reported 1.53 01/24 22 Apr 2024: estimate 1.68 22 Apr 2024: reported 1.80 04/24 17 Jul 2024: estimate 1.86 17 Jul 2024: reported 1.97 07/24 28 Oct 2024: estimate 1.93 28 Oct 2024: reported 2.06 10/24 30 Jan 2025: estimate 1.76 30 Jan 2025: reported 1.98 01/25 29 Apr 2025: estimate 2.17 29 Apr 2025: reported 2.28 04/25 17 Jul 2025: estimate 2.37 17 Jul 2025: reported 2.42 07/25 28 Oct 2025: estimate 2.31 28 Oct 2025: reported 2.25 10/25 04 Feb 2026: estimate 2.00 04 Feb 2026: reported 2.03 02/26 27 Apr 2026: estimate 1.65 27 Apr 2026: reported 1.65 04/26 20 Jul 2026: estimate 2.15 20 Jul 2026: reported 2.41 07/26 27 Oct 2026: estimate 2.24 27 Oct 2026: reported 2.46 10/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
03 Feb 2027 08:00 2.23 — — Upcoming
27 Oct 2026 06:00 2.24 2.46 +9.7% Beat
20 Jul 2026 20:00 2.15 2.41 +12.2% Beat
27 Apr 2026 22:00 1.65 1.65 +0.0% In line
04 Feb 2026 01:00 2.00 2.03 +1.3% Beat
28 Oct 2025 02:00 2.31 2.25 -2.6% Miss
17 Jul 2025 01:00 2.37 2.42 +2.0% Beat
29 Apr 2025 01:00 2.17 2.28 +5.0% Beat
30 Jan 2025 20:00 1.76 1.98 +12.7% Beat
28 Oct 2024 22:00 1.93 2.06 +6.6% Beat
17 Jul 2024 22:00 1.86 1.97 +5.9% Beat
22 Apr 2024 22:00 1.68 1.80 +6.9% Beat
30 Jan 2024 20:00 1.66 1.53 -7.7% Miss
24 Oct 2023 01:00 1.74 1.74 -0.2% In line
17 Jul 2023 21:00 1.76 1.83 +4.0% Beat
25 Apr 2023 01:00 1.53 1.71 +11.9% Beat
31 Jan 2023 20:00 1.43 1.52 +6.0% Beat
25 Oct 2022 01:00 1.62 1.58 -2.3% Miss
19 Jul 2022 01:00 1.54 1.56 +1.4% Beat
26 Apr 2022 01:00 1.51 1.46 -3.2% Miss
02 Feb 2022 01:00 1.41 1.40 -1.0% In line
26 Oct 2021 03:00 1.66 1.71 +3.2% Beat
21 Jul 2021 01:00 1.49 1.66 +11.7% Beat
27 Apr 2021 01:00 1.62 1.52 -6.2% Miss
25 Jan 2021 20:00 1.39 1.34 -3.8% Miss
27 Oct 2020 02:00 1.45 1.52 +4.9% Beat
21 Jul 2020 01:00 1.33 1.36 +2.1% Beat
28 Apr 2020 02:00 1.36 1.56 +15.0% Beat
28 Jan 2020 20:00 1.31 1.32 +1.0% Beat
22 Oct 2019 01:00 1.35 1.41 +4.6% Beat
18 Jul 2019 01:00 1.23 1.34 +8.5% Beat
24 Apr 2019 13:00 1.21 1.21 -0.2% In line
30 Jan 2019 01:00 1.30 1.25 -3.5% Miss
18 Oct 2018 01:00 1.34 1.32 -1.8% Miss
18 Jul 2018 01:00 1.28 1.29 +1.1% Beat
19 Apr 2018 02:00 1.27 1.28 +0.8% In line
24 Jan 2018 01:00 1.17 1.21 +3.8% Beat
24 Oct 2017 01:00 1.24 1.29 +3.8% Beat
18 Jul 2017 01:00 1.17 1.22 +4.6% Beat
25 Apr 2017 01:00 1.10 1.13 +2.3% Beat
25 Jan 2017 01:00 1.10 1.12 +1.4% Beat
25 Oct 2016 01:00 1.19 1.23 +3.3% Beat
19 Jul 2016 01:00 1.17 1.23 +5.2% Beat
21 Apr 2016 02:00 1.16 1.17 +1.2% Beat
27 Jan 2016 01:00 1.18 1.12 -5.5% Miss
27 Oct 2015 02:00 1.32 1.27 -3.5% Miss
21 Jul 2015 01:00 1.24 1.25 +0.8% In line
23 Apr 2015 01:00 1.09 1.29 +18.9% Beat
27 Jan 2015 01:00 1.18 1.21 +2.3% Beat
28 Oct 2014 03:00 1.30 1.37 +5.7% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 56.7B +9.6% 14B 24.7% 7.15 +21.8% 15.2B
2024 51.7B +10.8% 11.9B 23.1% 5.87 -17.3% 13.8B
2023 46.7B +7.4% 14.9B 31.8% 7.10 +124.0% 11.7B
2022 43.5B — 7B 16.0% 3.17 — 12B

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
10 May 2024 101.13 102.14 101.04 102.10 +1.89% 1,843,400
09 May 2024 99.72 100.29 99.44 100.21 +0.61% 1,384,400
08 May 2024 99.65 99.78 99.26 99.60 +0.53% 1,153,300
07 May 2024 98.60 99.19 98.54 99.07 +1.37% 1,159,700
06 May 2024 97.50 97.83 97.11 97.73 +0.47% 1,180,800
03 May 2024 97.75 97.91 97.07 97.27 -0.07% 1,045,700
02 May 2024 97.21 97.47 96.85 97.34 -0.16% 1,426,100
01 May 2024 96.97 97.87 96.72 97.50 +0.38% 1,284,200
30 Apr 2024 97.08 97.82 96.92 97.13 +0.04% 1,630,700
29 Apr 2024 97.76 97.91 96.86 97.09 -0.36% 2,144,400
26 Apr 2024 97.76 98.22 97.44 97.44 -1.64% 1,562,800
25 Apr 2024 98.63 99.24 98.26 99.06 +0.72% 2,421,300
24 Apr 2024 98.50 98.55 97.41 98.35 +1.10% 2,473,000
23 Apr 2024 98.74 99.50 97.03 97.28 +2.27% 3,837,400
22 Apr 2024 94.76 96.03 94.72 95.12 +0.81% 2,447,800
19 Apr 2024 93.20 94.50 93.15 94.36 +1.93% 2,338,300
18 Apr 2024 92.85 92.93 92.35 92.57 -0.55% 1,054,600
17 Apr 2024 93.63 93.78 92.87 93.08 -0.13% 1,168,700
16 Apr 2024 92.85 93.37 92.64 93.20 -1.28% 1,914,800
15 Apr 2024 94.20 94.97 94.11 94.41 +0.95% 1,501,000
12 Apr 2024 94.99 95.05 93.41 93.52 -0.87% 2,099,600
11 Apr 2024 94.87 94.91 93.75 94.34 -0.04% 1,623,300
10 Apr 2024 94.57 94.67 94.04 94.38 -1.49% 2,399,100
09 Apr 2024 95.67 95.90 95.39 95.81 +0.35% 1,373,900
08 Apr 2024 95.74 96.15 95.25 95.48 -0.32% 1,535,100

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
161.93 USD
Market cap
307.0B
Dividend yield
2.92%
5-year average yield
3.46%
Payout ratio
90%
Last dividend
4.7730 USD · 11 Mar 2026
Exchange
NYSE
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD

Dividends

Ex-dividend datePer share
11 Mar 20264.7730 USD
12 Mar 20253.9940 USD
07 Mar 20243.7400 USD
09 Mar 20233.4690 USD
08 Mar 20223.3570 USD
04 Mar 20213.3780 USD
03 Mar 20203.0420 USD
04 Mar 20192.5672 USD
06 Mar 20182.6676 USD
01 Mar 20172.4606 USD
24 Feb 20162.4749 USD
02 Mar 20152.5242 USD

Why this score

How the score is made up
Part of the scorePointsWhy
Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. 12.2 / 25
  • Yield of 2.9% on today's price
Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. 19.0 / 25
  • Dividend uses 56% of free cash flow (3-year average)
Dividend growth How many years in a row the dividend has risen, and how fast. 7.7 / 15
  • Dividend up 3 years in a row, 5.8% a year
Quality Return on equity, net margin and how stable the margins are. 10.4 / 15
  • ROE of 24%
Valuation Free cash flow yield and the P/E against its sector. 6.3 / 10
  • P/E 31.0 against 30.3 for its sector
Analysts How far the analysts' average target is from today's price. 0.9 / 5
  • Analysts' target is -5% from the price

Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 31.02× Weak 30.3×
P/E (forward) 16.35× Fair 14.94×
Price / book 8.25× Weak 3.81×
Price / sales 5.35× Weak 3.19×
EV / EBITDA 14.41× Fair 12.63×
Free cash flow yield 3.7% Fair 2.6%
Quality
FigureValueReading Sector median
Gross margin 75.2% Good 58.6%
Operating margin 34.3% Good 7.8%
Net margin 17.5% Good 2.8%
Return on equity 24.3% Good 5.7%
Return on assets 10.9% Good 3.6%
Growth
FigureValueReading Sector median
Revenue growth / year 9.3% Good 10.8%
EPS growth / year 31.1% Good 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 1.29× Fair 0.48×
Net debt / EBITDA 1.64× Fair 1.58×
Interest cover 15.42× Good 2.76×
Current ratio 0.88× Weak 2.35×
Dividends
FigureValueReading Sector median
Payout of earnings 90.5% Weak 0%
Payout of free cash flow 69.4% Fair 28.9%
Payout of free cash flow (3 years) 55.7% Fair —
Dividend growth / year 5.8% Good 7.1%
Years of rising dividends 3 Fair 3

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow NVS and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in